CID 146684890
Piricyclamide tlgcmngterclglp
Structural Information
- Molecular Formula
- C63H105N19O20S3
- SMILES
- C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1)CC(=O)N)CCSC)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC2=O)CC(C)C)CC(C)C)[C@@H](C)O)CC(C)C)CCCN=C(N)N)CCC(=O)O)O
- InChI
- InChI=1S/C63H105N19O20S3/c1-29(2)20-37-51(91)68-24-45(86)71-40(22-31(5)6)62(102)82-18-11-13-43(82)59(99)81-50(33(8)84)61(101)78-38(21-30(3)4)52(92)69-25-46(87)72-41-27-104-105-28-42(58(98)76-37)79-54(94)34(12-10-17-67-63(65)66)73-55(95)35(14-15-48(89)90)75-60(100)49(32(7)83)80-47(88)26-70-53(93)39(23-44(64)85)77-56(96)36(16-19-103-9)74-57(41)97/h29-43,49-50,83-84H,10-28H2,1-9H3,(H2,64,85)(H,68,91)(H,69,92)(H,70,93)(H,71,86)(H,72,87)(H,73,95)(H,74,97)(H,75,100)(H,76,98)(H,77,96)(H,78,101)(H,79,94)(H,80,88)(H,81,99)(H,89,90)(H4,65,66,67)/t32-,33-,34+,35+,36+,37+,38+,39+,40+,41-,42+,43+,49+,50+/m1/s1
- InChIKey
- CCULVWMSKMCNLG-UUKVWBFRSA-N
- Compound name
- 3-[(1R,4S,10S,16S,19S,22S,28S,31S,34S,40S,43S,46S)-34-(2-amino-2-oxoethyl)-46-[3-(diaminomethylideneamino)propyl]-19,40-bis[(1R)-1-hydroxyethyl]-4,10,22-tris(2-methylpropyl)-31-(2-methylsulfanylethyl)-2,5,8,11,17,20,23,26,29,32,35,38,41,44,47-pentadecaoxo-50,51-dithia-3,6,9,12,18,21,24,27,30,33,36,39,42,45,48-pentadecazatricyclo[26.20.4.012,16]dopentacontan-43-yl]propanoic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 1544.7019 | 304.5 |
[M+Na]+ | 1566.6838 | 304.7 |
[M-H]- | 1542.6873 | 292.6 |
[M+NH4]+ | 1561.7284 | 299.0 |
[M+K]+ | 1582.6578 | 282.5 |
[M+H-H2O]+ | 1526.6919 | 273.0 |
[M+HCOO]- | 1588.6928 | 298.5 |
[M+CH3COO]- | 1602.7085 | 299.8 |
[M+Na-2H]- | 1564.6693 | 305.8 |
[M]+ | 1543.6941 | 303.9 |
[M]- | 1543.6951 | 303.9 |
Literature stripe
Patent stripe
No patent data available for this compound.